1. Vesalius Research Center, Vlaams Iustituut voor Biotechnologie (VIB), Leuven, Belgium;
2. Vesalius Research Center, Katholieke Universiteit Leuven, Leuven, Belgium;
3. Molecular Cancer Biology Program, Biomedicum Helsinki, Haartman Institute, University of Helsinki, Helsinki, Finland;
4. IFOM, FIRC Institute of Molecular Oncology, Milan, Italy;
5. Hubrecht Institute-KNAW and UMC, Utrecht, The Netherlands;
6. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT;
7. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; and
8. Department of Biomolecular Sciences and Biotechnologies, University of Milan, Milan, Italy